arrow
A

Anand Swaminath

mcmaster university
H指数:30
被引数:6,951

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma treated with Stereotactic Ablative Radiotherapy
2026-01-220
OAAI
STEREOTACTIC BODY RADIOTHERAPY (SBRT) BOOST FOLLOWING URGENT 3D CONFORMAL RADIOTHERAPY FOR METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC): A PHASE 1 FEASIBILITY STUDY

立体定向体部放射治疗(SBRT)在紧急三维适形放射治疗后的加量治疗,用于治疗转移性硬膜外脊柱 cord 压迫(MESCC):一项可行性研究的第1阶段

2025-12-230
OAAI
Dosimetric Outcomes of SBRT to Ultra-central Lung Tumors: Lessons from the SUNSET trial

SBRT治疗超中心型肺癌的剂量学结果:SUNSET试验的经验

2025-09-030
OAAI
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the Kidney

立体定向消融体部放射治疗(SABR)在不常见类型原发性肾癌中的疗效:国际肾脏放射外科肿瘤学协作组(International Radiosurgery Oncology Consortium of the Kidney)的分析

2025-09-020
PRE
Primary Analysis of (NCT03380806) a Phase II Randomized Trial of Stereotactic Body Radiotherapy Boost Versus Conventional Fractionation External Beam Radiotherapy Boost in Unfavorable-Intermediate and High-Risk Prostate Cancer

(NCT03380806)一项关于立体定向体部放射治疗加量与常规分割外照射放射治疗加量在不良-中危和高危前列腺癌中的随机Ⅱ期试验的初步分析

2025-04-271
OAAI
Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Practice Guide
2025-01-012
PRE
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney

包括孤立肾患者在内的原发性肾细胞癌立体定向消融放疗后的长期肾功能预后: 国际肾脏放射外科肿瘤学联合会的报告

2024-12-013
PRE
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapy

生长分化因子15 (GDF15) 预测未切除局部晚期非小细胞肺癌放化疗的无复发生存率和总生存率

2024-11-071
OAAI
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)
2024-11-0118
OAAI